Who Can Help With The GLP-1 Shortage?
The sudden, rapid demand for glucagon-like peptide (GLP-1) medications has created major shortages. Individuals who require GLP-1 for significant health challenges like diabetes management and weight loss struggle to fill prescriptions. Thanks to recent regulatory approvals, compounding pharmacies are sometimes authorized to fill the gap. The ability of these facilities to help depends on sourcing high-quality active pharmaceutical ingredients (APIs) from reliable vendors. Sometimes, compounding pharmacies must source API vendors quickly. The GLP-1 shortage has shown that API sourcing can be difficult. Establishing strategic vendor relationships can restore patient access during supply crises.
Finding API vendors
Sourcing APIs for GLP-1 presents unique difficulties. Few facilities have the infrastructure to create high-purity ingredients. GLP-1 also contains proprietary molecules with limited manufacturers producing pharmaceutical-grade versions. The surge in demand strains supply chains and even compounding pharmacies are caught unprepared. Even those who do find suppliers, quality verification is critical. Peptides are delicate molecules that are easily degraded, requiring proper synthesis, purification, and storage. For compounding pharmacies to be successful in helping with shortages, the right API vendors matter. Each API must meet United States Pharmacopeia (USP) standards. Pharmacies must confirm legitimate sourcing to avoid counterfeit or diverted products while navigating regulatory compliance. This complexity makes vendor selection more challenging than sourcing standard drug ingredients.
Vet your suppliers
Helping to solve the GLP-1 crisis starts with responsible supplier vetting. Responsible compounding pharmacies must implement strict vendor qualification processes. Common practices include verifying inspection history, reviewing certificates of analysis (COA), documenting purity, and potency testing. Take time to audit supplier quality management systems and manufacturing practices. Confirm appropriate storage and shipping capabilities. Check references from other pharmacies using the supplier. Shortages mean companies with unverified claims can attempt to capitalize on the chaos. Look for red flags and avoid rash decisions by choosing supplies that cannot provide comprehensive, pharmaceutical-grade documentation.
Consider independent testing
Even with shortages, there are opportunities to perform independent testing. The best compounding pharmacies send API samples to third-party laboratories for identity verification. Consider confirming if the peptide matches the expected molecular structure. Potency testing ensures that the labeled strength is accurate, while purity analysis discovers contaminants or degradation products. Yes, testing can be costly and delays compounding, but this extra step protects patients and compounding pharmacies. Some pharmacies test every batch received, while others test initially, then periodically with trusted suppliers. A lack of testing, even with significant shortages, presents risks to patient health.
It’s about balance
The GLP-1 shortage creates pressure to prioritize availability over quality. Patients want access, and pharmacies are incentivized to meet demand. At the same time, API quality should never be compromised to meet demand. Compounded GLP-1 products that are even slightly compromised can lead to ineffective treatment and side effects. This damages the pharmacy's long-term reputation. Spend the additional time to source the best, most reputable vendors available. Consider placing orders or making strategic partnerships with API vendors in advance or based on trends. Resist the urge to cut corners or use unverified vendors. Pharmacies prioritizing quality over volume build long-term trust with healthcare providers and patients.
Make the right moves
Compounding pharmacies have come to the forefront of the GLP-1 shortage crisis. These facilities recreate GLP-1 alternatives to meet patient needs. This service requires compounding pharmacies to have high-quality APIs available. Sourcing and then building strategic partnerships with reputable API vendors becomes critical. Consider finding vendors who can increase ingredient demand while still providing the necessary verification requirements. A commitment to excellent ingredients means patients and compounding pharmacies thrive.
